Effects of galanin subchronic treatment on memory and muscarinic receptors

Neuroscience

Volumn 293, Issue , 2015, Pages 23-34

  Barreda Gomez G ^a   Lombardero, L ^a   Giralt, M T ^a   Manuel, I ^a   Rodriguez Puertas R ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Autoradiography; Galanin; Immunohistochemistry; Memory; Muscarinic receptors; ^{35< sup>S GTP S}

Indexed keywords

ACETYLCHOLINESTERASE; GALANIN; GALANIN RECEPTOR; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; OXOTREMORINE; PIRENZEPINE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE);

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; ENTORHINAL CORTEX; HIPPOCAMPUS; LEARNING; LOW DRUG DOSE; MALE; MEMORY; MEYNERT BASAL NUCLEUS; NONHUMAN; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; ANIMAL; ANTAGONISTS AND INHIBITORS; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; COGNITION DISORDERS; DRUG EFFECTS; ELECTRIC SHOCK; FOREBRAIN; METABOLISM; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACETYLCHOLINESTERASE; ANIMALS; AVOIDANCE LEARNING; BASAL FOREBRAIN; COGNITION DISORDERS; ELECTROSHOCK; GALANIN; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HIPPOCAMPUS; MALE; MEMORY; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GALANIN; RECEPTORS, MUSCARINIC;

EID: 84924918362     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.02.039     Document Type: Article

References (55)

1. Amoroso D., Girotti P., Fisone G., Bartfai T., Consolo S. Mechanism of the galanin induced increase in acetylcholine release in vivo from striata of freely moving rats. Brain Res 1992, 589:33-38.
2. Antoniou K., Kehr J., Snitt K., Ögren S.O. Differential effects of the neuropeptide galanin on striatal acetylcholine release in anaesthetized and awake rats. Br J Pharmacol 1997, 121:1180-1186.
3. Barreda-Gómez G., Giralt M.T., Rodríguez-Puertas R. Effects of central galanin administration on muscarinic cholinergic and galanin receptor G protein coupling. Neuropeptides 2005, 39:157-160.
4. Baskin D.G., Wimpy T.H. Calibration of [14C]plastic standards for quantitative autoradiography of [125I]labeled ligands with Amersham Hyperfilm beta-max. Neurosci Lett 1989, 104:171-177.
5. Beal M.F., MacGarvey U., Swartz K.J. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Ann Neurol 1990, 28:157-161.
6. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 1988, 273:543-557.
7. Cheng Y., Yu L.C. Galanin protects amyloid-beta-induced neurotoxicity on primary cultured hippocampal neurons of rats. J Alzheimers Dis 2010, 20:1143-1157.
8. Cortés R., Probst A., Palacios J.M. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: brainstem. Neuroscience 1984, 12:1003-1026.
9. Cortés R., Villar M.J., Verhofstad A., Hokfelt T. Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. Proc Natl Acad Sci U S A 1990, 87:7742-7746.
10. Cui J., Chen Q., Yue X., Jiang X., Gao G.F., Yu L.C., Zhang Y. Galanin protects against amyloid toxicity in human primary neurons. J Alzheimers Dis 2010, 19:529-544.
11. Diez M., Koistinaho J., Kahn K., Games D., Hökfelt T. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein H,-initial observations. Neuroscience 2000, 100:259-286.
12. Ding X., MacTavish D., Kar S., Jhamandas J.H. Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons. Neurobiol Dis 2006, 21:413-420.
13. Elvander E., Schott P.A., Sandin J., Bjelke B., Kehr J., Yoshitake T., Ögren S.O. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition. Neuroscience 2004, 126:541-557.
14. Fisone G., Wu C.F., Consolo S., Nordstrom O., Brynne N., Bartfai T., Melander T., Hökfelt T. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo and in vitro studies. Proc Natl Acad Sci U S A 1987, 84:7339-7343.
15. Hajos N., Papp E.C., Acsady L., Levey A.I., Freund T.F. Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience 1998, 82:355-376.
16. Hökfelt T., Millhorn D., Seroogy K., Tsuruo Y., Ceccatelli S., Lindh B., Meister B., Melander T., Schalling M., Bartfai T., et al. Coexistence of peptides with classical neurotransmitters. Experientia 1987, 43:768-780.
17. Jhamandas J.H., Harris K.H., MacTavish D., Jassar B.S. Novel excitatory actions of galanin on rat cholinergic basal forebrain neurons: implications for its role in Alzheimer's disease. Neurophysiology 2002, 87:696-704.
18. Kinney J.W., Starosta G., Holmes A., Wrenn C.C., Yang R.J., Harris A.P., Long K.C., Crawley J.N. Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learn Mem 2002, 9:178-190.
19. Kinney J.W., Starosta G., Crawley J.N. Central galanin administration blocks consolidation of spatial learning. Neurobiol Learn Mem 2003, 80:42-54.
20. Köhler C., Persson A., Melander T., Theodorsson E., Sedvall G., Hökfelt T. Distribution of galanin-binding sites in the monkey and human telencephalon: preliminary observations. Exp Brain Res 1989, 75(2):375-380.
21. Lang R., Gundlach A.L., Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther 2007, 115:177-207.
22. Laplante F., Crawley J.N., Quirion R. Selective reduction in ventral hippocampal acetylcholine release in awake galanin-treated rats and galanin-overexpressing transgenic mice. Reg Peptides 2004, 122:91-98.
23. Levey A.I., Edmunds S.M., Hersch S.M., Wiley R.G., Heilman C.J. Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat. J Comp Neurol 1995, 351:339-356.
24. Li L., Yu L., Kong Q. Exogenous galanin attenuates spatial memory impairment and decreases hippocampal beta-amyloid levels in rat model of Alzheimer's disease. Int J Neurosci 2013, 123:759-765.
25. Malin D.H., Novy B.J., Lett-Brown A.E., Plotner R.E., May B.T., Radulescu S.J., Crothers M.K., Osgood L.D., Lake J.R. Galanin attenuates retention of one-trial reward learning. Life Sci 1992, 50:939-944.
26. Mataró M., Poca M.A., Del Mar Matarin M., Catalan R., Sahuquillo J., Galard R. CSF galanin and cognition after shunt surgery in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2003, 74:1272-1277.
27. Melander T., Staines W.A., Hokfelt T., Rokaeus A., Eckenstein F., Salvaterra P.M., Wainer B.H. Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat. Brain Res 1985, 360:130-138.
28. Melander T., Hökfelt T., Rokaeus A., Cuello A.C., Oertel W.H., Verhofstad A., Goldstein M. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci 1986, 6:3640-3654.
29. Melander T., Köhler C., Nilsson S., Hökfelt T., Brodin E., Theodorsson E., Bartfai T. Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J Chem Neuroanat 1988, 1:213-233.
30. Mufson E.J., Cochran E., Benzing W., Kordower J.H. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 1993, 4:237-250.
31. Mufson E.J., Deecher D.C., Basile M., Izenwasse S., Mash D.C. Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis. Neuropharmacology 2000, 39:1404-1412.
32. Mufson E.J., Counts S.E., Perez S.E., Binder L. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice. Neuropeptides 2005, 39:233-237.
33. O'Meara G., Coumis U., Ma S.Y., Kehr J., Mahoney S., Bacon A., Allen S.J., Holmes F., Kahl U., Wang F.H., Kearns I.R., Ove-Ögren S., Dawbarn D., Mufson E.J., Davies C., Dawson G., Wynick D. Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci U S A 2000, 97:11569-11574.
34. Ögren S.O., Pramanik A. Galanin stimulates acetylcholine release in the rat striatum. Neurosci Lett 1991, 128:253-256.
35. Ögren S.O., Kehr J., Schott P.A. Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat. Neuroscience 1996, 75:1127-1140.
36. Ögren S.O., Schott P.A., Kehr J., Misane I., Rasan H. Galanin and learning. Brain Res 1999, 848:174-182.
37. Palazzi E., Felinska S., Zambelli M., Fisone G., Bartfai T., Consolo S. Galanin reduces carbachol stimulation of phosphoinositide turnover in rat ventral hippocampus by lowering Ca2+ influx through voltage-sensitive Ca2+ channels. J Neurochem 1991, 56:739-747.
38. Pérez S., Basile M., Mash D.C., Mufson E.J. Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis. J Chem Neuroanat 2002, 24:109-116.
39. Quirion R., Araujo D., Regenold W., Boksa P. Characterization and quantitative autoradiographic distribution of [3H]acetylcholine muscarinic receptors in mammalian brain. Apparent labelling of an M2-like receptor sub-type. Neuroscience 1989, 29:271-289.
40. Robinson J.K., Crawley J.N. Intraventricular galanin impairs delayed nonmatching-to-sample performance in rats. Behav Neurosci 1993, 107:458-467.
41. Rodríguez-Puertas R., Nilsson S., Pascual J., Pazos A., Hokfelt T. 125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus. J Neurochem 1997, 68:1106-1113.
42. Rodríguez-Puertas R., Pascual J., Vilaró T., Pazos A. Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease. Synapse 1997, 26:341-350.
43. Rodríguez-Puertas R., González-Maeso J., Meana J.J., Pazos A. Autoradiography of receptor-activated G-proteins in post mortem human brain. Neuroscience 2000, 96:169-180.
44. Schött P.A., Hökfelt T., Ogren S.O. Galanin and spatial learning in the rat. Evidence for a differential role for galanin in subregions of the hippocampal formation. Neuropharmacology 2000, 39(8):1386-1403.
45. Seeger T., Fedorova I., Zheng F., Miyakawa T., Koustova E., Gomeza J., Basile A.S., Alzheimer C., Wess J. M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J Neurosci 2004, 24:10117-10127.
46. Shim I., Ha Y., Chung J.Y., Lee H.J., Yang K.H., Chang J.W. Association of learning and memory impairments with changes in the septohippocampal cholinergic system in rats with kaolin-induced hydrocephalus. Neurosurgery 2003, 53:416-425.
47. Spencer D.G., Horvath E., Traber J. Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections. Brain Res 1986, 380:59-68.
48. Steiner R.A., Hohmann J.G., Holmes A., Wrenn C.C., Cadd G., Jureus A., Clifton D.K., Luo M., Gutshall M., Ma S.Y., Mufson E.J., Crawley J.N. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc Natl Acad Sci U S A 2001, 98:4184-4189.
49. Sundstrom E., Archer T., Melander T., Hokfelt T. Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze. Neurosci Lett 1988, 88:331-335.
50. Tago H., Kimura H., Maeda T. Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. J Histochem Cytochem 1986, 34:1431-1438.
51. Tashiro Y., Drake J.M., Chakrabortty S., Hattori T. Functional injury of cholinergic, GABAergic and dopaminergic systems in the basal ganglia of adult rat with kaolin-induced hydrocephalus. Brain Res 1997, 770:45-52.
52. Ukai M., Miura M., Kameyama T. Effects of galanin on passive avoidance response, elevated plus-maze learning, and spontaneous alternation performance in mice. Peptides 1995, 16:1283-1286.
53. Vilaró M.T., Wiederhold K.H., Palacios J.M., Mengod G. Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience 1992, 47:367-393.
54. Vogt B.A., Gabriel M., Vogt L.J., Poremba A., Jensen E.L., Kubota Y., Kang E. Muscarinic receptor binding increases in anterior thalamus and cingulate cortex during discriminative avoidance learning. J Neurosci 1991, 11:1508-1514.
55. Wang H.Y., Wild K.D., Shank R.P., Lee D.H. Galanin inhibits acetylcholine release from rat cerebral cortex via a pertussis toxin-sensitive G(i)protein. Neuropeptides 1999, 33:197-205.